Table 1.
Omega-3 | Placebo | p value | |
---|---|---|---|
Cases | 162 | 153 | |
BMI, mean (SD) | 26.0 (6.1) | 26.1 (6.9) | 0.81 |
Race, N(%) | 0.89 | ||
African American | 43 (26.5%) | 44 (28.8%) | |
Hispanic | 24 (14.8%) | 21 (13.7%) | |
Caucasian | 95 (58.6%) | 88 (57.5%) | |
GA (weeks) @ sample time, mean (SD) | 27.0 (1.4) | 26.9 (1.5) | 0.25 |
GA (weeks) @ delivery, mean (SD) | 37.4 (2.3) | 37.0 (3.0) | 0.76 |
Progesterone (ng/ml), mean (SD) | 72.4 (26.9) | 70.5 (22.1) | 0.63 |
17-OHPC (ng/ml), mean (SD) | 11.3 (5.8) | 10.7 (4.0) | 0.79 |
# of injections at time of blood sample, median (interquartile range) |
9 (7-10) | 9 (7-10) | 0.26 |
Delivery < 37 0/7 weeks | 53 (32.7%) | 53 (34.6%) | 0.72 |